[Anticoagulants. Various developmental starting points on direct antithrombins as antithrombotic agents].
D000578:Amidines / Q000627:therapeutic use; D062365:Aminobenzoates / Q000627:therapeutic use; D000991:Antithrombins / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D024764:Hirudin Therapy; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D013300:Streptokinase / Q000037:antagonists & inhibitors; D013924:Thrombophlebitis / Q000188:drug therapy*; D013927:Thrombosis / Q000188:drug therapy*
D000578:Amidines; D062365:Aminobenzoates; D000991:Antithrombins; D003509:Cyclohexanecarboxylic Acids; D005343:Fibrinolytic Agents; D013300:Streptokinase
Antikoagulatien. Uber einige Entwicklungs-Ansatzpunkte über Direktantithrombine als Antithrombotika